These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28645474)

  • 41. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
    Kurtul A; Acikgoz SK
    Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era.
    Nakatani D; Sakata Y; Suna S; Usami M; Matsumoto S; Shimizu M; Hara M; Uematsu M; Fukunami M; Hamasaki T; Sato H; Hori M; Komuro I;
    Am J Cardiol; 2013 Feb; 111(4):457-64. PubMed ID: 23228922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention--results from a randomized study.
    Lønborg J; Kelbæk H; Helqvist S; Holmvang L; Jørgensen E; Saunamäki K; Kløvgaard L; Kaltoft A; Bøtker HE; Lassen JF; Thuesen L; Terkelsen CJ; Kofoed KF; Clemmensen P; Køber L; Engstrøm T
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):180-8. PubMed ID: 25013089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doppler tissue imaging is an independent predictor of outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Biering-Sørensen T; Jensen JS; Pedersen S; Galatius S; Hoffmann S; Jensen MT; Mogelvang R
    J Am Soc Echocardiogr; 2014 Mar; 27(3):258-67. PubMed ID: 24325959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term outcomes after invasive management for older patients with non-ST-segment elevation myocardial infarction.
    Roe MT; Li S; Thomas L; Wang TY; Alexander KP; Ohman EM; Peterson ED
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):323-32. PubMed ID: 23652734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
    Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of presenting electrocardiographic findings on the treatment and outcomes of patients with non-ST-segment elevation myocardial infarction.
    Patel JH; Gupta R; Roe MT; Peng SA; Wiviott SD; Saucedo JF
    Am J Cardiol; 2014 Jan; 113(2):256-61. PubMed ID: 24290492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between culprit artery and the clinical outcomes in patients undergoing primary percutaneous coronary ıntervention for ınferior wall ST segment elevation myocardial ınfarction.
    Ayhan E; Isik T; Ghannadian B; Akgül O; Alagic N
    Minerva Cardioangiol; 2016 Aug; 64(4):367-74. PubMed ID: 25516137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
    De Luca G; Sauro R; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Palmieri V; Serino V; Rosato G; Suryapranata H; Di Lorenzo E
    Diab Vasc Dis Res; 2015 Sep; 12(5):306-14. PubMed ID: 26150193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presence of sigma shaped right coronary artery is an indicator of poor prognosis in patients with inferior myocardial infarction treated with primary percutaneous coronary intervention.
    Güngör B; Alper AT; Ozcan KS; Ekmekçi A; Karadeniz FÖ; Mutluer FO; Kaya A; Karataş B; Osmonov D; Bolca O
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):965-72. PubMed ID: 24402881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes of ST Elevation Myocardial Infarction Complicated by Out-of-Hospital Cardiac Arrest (from the Los Angeles County Regional System).
    Shavelle DM; Bosson N; Thomas JL; Kaji AH; Sung G; French WJ; Niemann JT
    Am J Cardiol; 2017 Sep; 120(5):729-733. PubMed ID: 28728743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
    JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the presence of chronically occluded coronary artery on long-term prognosis of patients with acute ST-segment elevation myocardial infarction.
    Lesiak M; Cugowska M; Araszkiewicz A; Grygier M; Pyda M; Skorupski W; Mitkowski P; Łanocha M; Grajek S
    Cardiol J; 2017; 24(2):117-124. PubMed ID: 27910082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of Early Discharge After Primary Percutaneous Coronary Intervention.
    Satılmısoglu MH; Gorgulu S; Aksu HU; Aksu H; Ertaş G; Tasbulak O; Buturak A; Kalkan AK; Degirmencioglu A; Koroglu B; Tusun E; Murat A; Oz A
    Am J Cardiol; 2016 Jun; 117(12):1911-6. PubMed ID: 27156829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
    Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of CHA2DS2-VASc score in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
    Satilmisoglu MH; Gul M; Yildiz G; Akgul O; Kaya M; Cakmak HA; Akkaya E; Aslan S; Ameri MT; Ozyilmaz SO; Yildirim A
    Acta Cardiol; 2016; 71(6):663-669. PubMed ID: 27920453
    [No Abstract]   [Full Text] [Related]  

  • 59. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
    De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW;
    Arch Cardiovasc Dis; 2013 Mar; 106(3):155-61. PubMed ID: 23582677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.
    Stone SG; Serrao GW; Mehran R; Tomey MI; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Brener SJ; Dangas G; Stone GW
    Circ Cardiovasc Interv; 2014 Aug; 7(4):543-51. PubMed ID: 24939928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.